Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-070022
Filing Date
2021-12-16
Accepted
2021-12-16 17:18:49
Documents
1
Period of Report
2021-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6334
  Complete submission text file 0001209191-21-070022.txt   7681
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Issuer) CIK: 0001751299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address KALEIDO BIOSCIENCES, INC. 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address
Long Alison S (Reporting) CIK: 0001891712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38822 | Film No.: 211498561